Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 701–800 of 1,005

1. First Diagnosis of Atrial Fibrillation at the Time of Stroke
   Leila H. Borowsky, Susan Regan, Yuchiao Chang, Alison M. Ayres, Steven Mark Greenberg, Daniel E. Singer · 2017 · Cerebrovascular Diseases
2. Antithrombotic Therapy in Atrial Fibrillation - Evaluation and Positioning of New Oral Anticoagulant Agents -
   Satoshi Ogawa, Yukihiro Koretsune, Masahiro Yasaka, Yoshifusa Aizawa, Hirotsugu Atarashi, Hiroshi Inoue, Shiro Kamakura, Koichiro Kumagai, Hideo Mitamura, Ken Okumura et al. · 2011 · Circulation Journal
3. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke
   Emer R. McGrath, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, Margaret C. Fang, Kristi Reynolds, Daniel E. Singer · 2016 · Journal of the American Geriatrics Society
4. Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation
   Peter Sinnaeve, Martina Brueckmann, Andreas Clemens, Jonas Oldgren, John W. Eikelboom, J. Healey · 2011 · Journal of Internal Medicine
5. New antithrombotic agents—insights from clinical trials
   Jeremy S. Paikin, John W. Eikelboom, John A. Cairns, Jack Hirsh · 2010 · Nature Reviews Cardiology
6. Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control
   Andrej Janžič, Mitja Kos · 2014 · PharmacoEconomics
7. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists
   Hilde Kooistra, Agneta Calf, Margriet G Piersma-Wichers, Hanneke C. Kluin‐Nelemans, Gerbrand J. Izaks, Nic J.G.M. Veeger, Karina Meijer · 2016 · JAMA Internal Medicine
8. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
   Jean Hai Ein Yong, Kednapa Thavorn, Jeffrey S. Hoch, Muhammad Mamdani, Kevin E. Thorpe, Paul Dorian, Mike Sharma, Andreas Laupacis, David J. Gladstone · 2016 · Stroke
9. CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closure
   Edinrin R. Obasare, Sumeet K. Mainigi, D. Lynn Morris, Leandro N. Slipczuk, Igor Goykhman, Evan J. Friend, Mary Rodriguez Ziccardi, Gregg S. Pressman · 2017 · International journal of cardiac imaging
10. Application of net reclassification index to non-nested and point-based risk prediction models: a review
    Laine Elliott Thomas, Emily Claire O'Brien, Jonathan Paul Piccini, Ralph B. D’Agostino, Michael J. Pencina · 2018 · European Heart Journal
11. Stroke in the elderly
    Anjail Zarinah Sharrief, James C. Grotta · 2019 · Handbook of clinical neurology
12. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
    Chen, Fangzhe, Wang, Weifeng, Ding, Hongyan, Yang, Qi, Dong, Qiang, Cui, Mei · 2016 · Journal of Neuroinflammation
13. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions
    Jeremy S. Paikin, Jack Hirsh, Mandy N. Lauw, John W. Eikelboom, Jeffrey S. Ginsberg, Noel Chan · 2014 · Thrombosis and Haemostasis
14. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial
    Jonathan G. Best, Elizabeth Arram, Norin Ahmed, Maryam Balogun, Kate Bennett, Ekaterina Bordea, Marta G Campos, Emilia Caverly, Marisa Chau, Hannah Cohen et al. · 2022 · International Journal of Stroke
15. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives
    Ulf Landmesser, Carsten Skurk, Apostolos Tzikas, Volkmar Falk, Vivek Yerrapu Reddy, Stephan Windecker · 2024 · European Heart Journal
16. Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study
    Gabriel S.C. Yiin, Dominic P. J. Howard, Nicola L. M. Paul, Linxin Li, Ziyah Mehta, Peter Malcolm Rothwell · 2015 · Journal of Neurology Neurosurgery & Psychiatry
17. Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation
    Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Anders Gorst‐Rasmussen, Flemming Skjøth, Lars Hvilsted Rasmussen, Gregory Y.H. Lip · 2014 · CHEST Journal
18. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation
    Yutao Guo, Haijun Wang, Xiaoning Zhao, Yu Zhang, Dexian Zhang, Jingling Ma, Yutang Wang, Gregory Y.H. Lip · 2013 · International Journal of Cardiology
19. The genetics of ischaemic stroke
    Mar Matarín, Andrew Singleton, John Hardy, James Frederick Meschia · 2009 · Journal of Internal Medicine
20. Minimizing the Risk of Bleeding with NOACs in the Elderly
    Amartya Kundu, Partha Sardar, Saurav Chatterjee, Wilbert S. Aronow, Theophilus Owan, John Jake Ryan · 2016 · Drugs & Aging
21. Patient values and preferences for antithrombotic therapy in atrial fibrillation
    Peter S Loewen, Tianshu Angela Ji, Anita I. Kapanen, Alison R. McClean · 2017 · Thrombosis and Haemostasis
22. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
    Ziad Hijazi, Jonas Oldgren, Ulrika Andersson, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Paul A. Reilly, Salim Yusuf, Agneta Siegbahn, Lars C. Wallentin · 2017 · American Heart Journal
23. Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
    Anneka Mitchell, Margaret C Watson, Tomas James Welsh, Anita McGrogan · 2019 · Journal of Clinical Medicine
24. Persistence of non‐vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single‐center observational study
    Tsuyoshi Shiga, Miyoko Naganuma, Takehiko Nagao, Kenji Maruyama, Atsushi Suzuki, Kagari Murasaki, Nobuhisa Hagiwara · 2015 · Journal of Arrhythmia
25. Barriers to Anticoagulation in Patients With Atrial Fibrillation
    Deirdre A. Lane, Gregory Y.H. Lip · 2007 · Stroke
26. Remote Cardiac Rhythm Monitoring in the Era of Smart Wearables: Present Assets and Future Perspectives
    Anastasia Xintarakou, Vasileios Sousonis, Dimitrios Asvestas, Panos E. Vardas, Stylianos E. Tzeis · 2022 · Frontiers in Cardiovascular Medicine
27. Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation
    Vera H W van der Endt, Jet Milders, Bas B. L. Penning de Vries, Serge A.I.P. Trines, Rolf H. H. Groenwold, Olaf M. Dekkers, Marco Trevisan, Juan Jesús Carrero, Merel van Diepen, Friedo Wilhelm Dekker et al. · 2022 · EP Europace
28. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines
    Kunal Bhatia, Lindsey Ladd, Kelsey Carr, Mario Di Napoli, Jeffrey L. Saver, Louise D. McCullough, Maryam Hosseini Farahabadi, Diana L. Alsbrook, Archana Hinduja, Jorge Ortiz-Garcia et al. · 2023 · Current Neurology and Neuroscience Reports
29. Outcomes After Kidney Transplantation of Patients Previously Diagnosed With Atrial Fibrillation
    Colin R. Lenihan, Maria E. Montez‐Rath, John D. Scandling, Mintu P. Turakhia, Wolfgang C. Winkelmayer­ · 2013 · American Journal of Transplantation
30. Relationship between Plasma D -Dimer Level and Cerebral Infarction Volume in Patients with Nonvalvular Atrial Fibrillation
    Mari Matsumoto, Manabu Sakaguchi, Shuhei Okazaki, Shigetaka Furukado, Masafumi Tagaya, Hideki Etani, Takeshi Shimazu, Toshiki Yoshimine, Hideki Mochizuki, Kazuo Kitagawa · 2013 · Cerebrovascular Diseases
31. Differences in Anticoagulant Therapy Prescription in Patients with Paroxysmal Versus Persistent Atrial Fibrillation
    Jonathan Chong Hsu, Paul Shing-fong Chan, Fengming Tang, Thomas M. Maddox, Gregory M. Marcus · 2014 · The American Journal of Medicine
32. Quality of Care and Outcomes in Women Hospitalized for Heart Failure
    Liviu Klein, Maria V. Grau‐Sepulveda, Robert O. Bonow, Adrian F. Hernandez, Mark V. Williams, Deepak L. Bhatt, Gregg C. Fonarow · 2011 · Circulation Heart Failure
33. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
    Renato D. Lópes, Meena P. Rao, DaJuanicia N. Simon, Laine Elliott Thomas, Jack Ansell, Gregg C. Fonarow, Bernard John Gersh, Alan S. Go, Elaine M. Hylek, Peter Russell Kowey et al. · 2016 · The American Journal of Medicine
34. Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies
    Kasper Adelborg, Erik Lerkevang Grove, Jens Sundbøll, Maja Laursen, Morten Schmidt · 2016 · Heart
35. Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
    Young-Ah Park, Jae‐Sun Uhm, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung · 2016 · Heart Rhythm
36. Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
    Hee Tae Yu, Pil‐Sung Yang, Tae‐Hoon Kim, Eunsun Jang, Daehoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Gregory Y.H. Lip et al. · 2018 · Stroke
37. Accuracy and Usability of a Novel Algorithm for Detection of Irregular Pulse Using a Smartwatch Among Older Adults: Observational Study
    Eric Ding, Dong Han, Cody Whitcomb, Syed Khairul Bashar, Oluwaseun Adaramola, Apurv Soni, Jane S. Saczynski, Timothy P. Fitzgibbons, Majaz Moonis, Steven A. Lubitz et al. · 2019 · JMIR Cardio
38. Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
    Colleen M. Hanley, Peter Russell Kowey · 2015 · Europe PMC (PubMed Central)
39. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Shannon O. Armstrong, Stacey L. Amorosi, N.J. Brereton, Deanna S. Hertz, David R. Holmes · 2016 · EP Europace
40. Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery
    Sameer Prasada, Milind Y. Desai, Marwan S Saad, Nathaniel Rosso Smilowitz, Michael D. Faulx, Venu Menon, Rohit Moudgil, Pulkit Chaudhury, Ayman Ali Hussein, Tyler Louis Taigen et al. · 2022 · Journal of the American College of Cardiology
41. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
    Tobias Toennis, Emanuele Bertaglia, Axel Brandes, Wolfgang Dichtl, Nina Fluschnik, Joris R. de Groot, Éloi Marijon, Lluı́s Mont, Carina Blomström‐Lundqvist, Nuno Cabanelas et al. · 2023 · EP Europace
42. Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III
    Stuart J. Connolly, Jeff S. Healey, Emilie P. Belley‐Côté, Kumar Balasubramanian, Domenico Paparella, Katheryn Brady, Wilko Reents, Bernhard Christoph Danner, Philip James Devereaux, Mukul Sharma et al. · 2023 · Circulation
43. Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
    Reza Hajhosseiny, Gareth D. K. Matthews, Gregory Y.H. Lip · 2015 · Heart Rhythm
44. Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
    Paul P. Dobesh, John R. Fanikos · 2015 · Drugs
45. Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
    Tatjana Potpara, Gregory Y.H. Lip · 2015 · Progress in Cardiovascular Diseases
46. Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
    William Guy Herrington, Richard Haynes, Natalie Staplin, Jonathan Emberson, Colin Baigent, Martin Landray · 2014 · Seminars in Dialysis
47. Asian strategy for stroke prevention in atrial fibrillation
    Chern‐En Chiang, Kang-Ling Wang, Shing‐Jong Lin · 2015 · EP Europace
48. Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
    Surapon Nochaiwong, Chidchanok Ruengorn, Rattanaporn Awiphan, Phongsak Dandecha, Kajohnsak Noppakun, Arintaya Phrommintikul · 2016 · Open Heart
49. Application of 3D printing technology to left atrial appendage occlusion
    Huakang Li, Qingyao, BingShen, Maoqin Shu, Lizhong, Xueqin Wang, Zhiyuan Song · 2017 · International Journal of Cardiology
50. Use of Non‐Vitamin K Antagonist Oral Anticoagulants 2008–2016: A Danish Nationwide Cohort Study
    Simone Bonde Haastrup, Maja Hellfritzsch, Lotte Rasmussen, Anton Pottegård, Erik Lerkevang Grove · 2018 · Basic & Clinical Pharmacology & Toxicology
51. Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study
    Sara Sekelj, Belinda C. Sandler, Ellie Johnston, Kevin G Pollock, Nathan R. Hill, Jason P. Gordon, Carmen Tsang, Sadia N Khan, Fu Siong Ng, Usman Farooqui · 2020 · European Journal of Preventive Cardiology
52. Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration
    Giuseppe Boriani, Renate B. Schnabel, Jeff S. Healey, Renato D. Lópes, Nicole Verbiest-van Gurp, Trudie Lobban, A. John Camm, Ben Freedman · 2020 · European Journal of Internal Medicine
53. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
    Alexander Philipp Benz, Ziad Hijazi, Johan Lindbäck, Stuart J. Connolly, John W. Eikelboom, Jonas Oldgren, Agneta G Siegbahn, Lars C. Wallentin · 2021 · Circulation
54. Fighting Against Stroke in Latin America: A Joint Effort of Medical Professional Societies and Governments
    Sheila Cristina Ouriques Martins, Pablo M. Lavados, Thaís Leite Secchi, Michael Brainin, Sebastian Francisco Ameriso, Fernando Góngora‐Rivera, Claudio Sacks, Carlos Gerardo Cantú-Brito, Tony Fabian Alvarez Guzman, Germán Enrique Pérez-Romero et al. · 2021 · Frontiers in Neurology
55. Perioperative challenges of atrial fibrillation
    Ivan Philip, Clarisse Berroëta, Isabelle Leblanc · 2014 · Current Opinion in Anaesthesiology
56. Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
    Tomoyuki Nagao, Yasuya Inden, Masayuki Shimano, Masaya Fujita, Satoshi Yanagisawa, Hiroyuki Kato, Shinji Ishikawa, Aya Miyoshi, SATOSHI OKUMURA, Shiou Ohguchi et al. · 2014 · Pacing and Clinical Electrophysiology
57. Drug adherence in patients taking oral anticoagulation therapy
    Sebastian Ewen, Volker Rettig‐Ewen, Felix Mahfoud, Michael Böhm, Ulrich Laufs · 2013 · Clinical Research in Cardiology
58. The risks of risk scores for stroke risk assessment in atrial fibrillation
    Tze‐Fan Chao, Peter Brønnum Nielsen · 2015 · Thrombosis and Haemostasis
59. Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016)
    Martin Wehling, Rónán Collins, Victor Machado Gil, Olivier Hanon, Roland Hardt, Martin Hoffmeister, Pedro F. Monteiro, Terence J. Quinn, Dieter Ropers, Giuseppe Sergi et al. · 2017 · Drugs & Aging
60. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial
    Marcello Disertori, Maria Grazia Franzosi, Simona Barlera, Franco Cosmi, Silvia Quintarelli, Chiara Favero, Glauco Cappellini, Gianna Fabbri, Aldo Pietro Maggioni, Lidia Irene Staszewsky et al. · 2013 · BMC Cardiovascular Disorders
61. Thromboembolic Prevention in Frail Elderly Patients With Atrial Fibrillation: A Practical Algorithm
    Serena Granziera, Alexander Thomas Cohen, Giovanni Nante, Enzo Manzato, Giuseppe Sergi · 2015 · Journal of the American Medical Directors Association
62. On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation
    Mika Skeppholm, Paul Hjemdahl, Jovan P. Antović, Josephine Muhrbeck, Jaak Eintrei, Yuko Rönquist-Nii, Anton Pohanka, Olof Beck, Rickard E. Malmström · 2014 · Thrombosis Research
63. CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome
    Jesper Hastrup Svendsen, Jens Cosedis Nielsen, Stine Darkner, Gunnar V.H. Jensen, Leif Spange Mortensen, Henning Andersen, on behalf of the DANPACE Investigators · 2013 · Heart
64. A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    Stephen A. LaHaye, Sabra Lynn Gibbens, David G. A. Ball, Andrew G. Day, Jonas Bjerring Olesen, Allan Cameron Skanes · 2012 · European Heart Journal
65. Why switch from warfarin to NOACs?
    Paolo Verdecchia, Fabio Angeli, Adolfo Aita, Claudia Bartolini, Gianpaolo Reboldi · 2016 · Internal and Emergency Medicine
66. Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation
    Eri Toda Kato, Shinya Goto, Robert Patrick Giugliano · 2018 · Ageing Research Reviews
67. Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study
    Apurv Soni, Sunil Karna, Nisha Fahey, Saket Sanghai, Harshil Anurag Patel, Shyamsundar Jagdish Raithatha, Sunil Thanvi, Somashekhar Marutirao Nimbalkar, Ben Freedman, Jeroan J. Allison et al. · 2018 · International Journal of Cardiology
68. Atrial Fibrillation and Stroke
    Hani Essa, Andrew M. Hill, Gregory Y.H. Lip · 2021 · Cardiac Electrophysiology Clinics
69. Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
    Robert Patrick Giugliano, Christian Thomas Ruff, Natalia S. Rost, Scott B. Silverman, Stephen D. Wiviott, Cheryl Lowe, Naveen Deenadayalu, Sabina A. Murphy, Laura T. Grip, Joshua Betcher et al. · 2014 · Stroke
70. The Gap between Trial Data and Clinical Practice - An Analysis of Case Reports on Bleeding Complications Occurring under Dabigatran and Rivaroxaban Anticoagulation
    Waltraud Pfeilschifter, Sebastian Luger, Robert Brunkhorst, Edelgard Lindhoff‐Last, Christian Foerch · 2013 · Cerebrovascular Diseases
71. Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor
    Gregory Y.H. Lip, Flemming Skjøth, Peter Brønnum Nielsen, Jette Nordstrøm Kjældgaard, Torben Bjerregaard Larsen · 2017 · JAMA Cardiology
72. Atrial fibrillation screening with photo-plethysmography through a smartphone camera
    Frederik Hendrik Verbrugge, Tine Proesmans, Johan M. Vijgen, Wilfried Müllens, Máximo Rivero‐Ayerza, Hugo Van Herendael, Pieter M. Vandervoort, Dieter Nuyens · 2019 · EP Europace
73. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
    Frank J.S. Cools, Dana Johnson, Alan John Camm, Jean‐Pierre Bassand, Freek W.A. Verheugt, Shu Yang, Anastasios A. Tsiatis, David Andrew Fitzmaurice, Samuel Zachary Goldhaber, Gloria Kayani et al. · 2021 · Journal of Thrombosis and Haemostasis
74. Management of atrial fibrillation in older adults
    Anna L. Parks, David S. Frankel, Dae Hyun Kim, Darae Ko, Daniel Bruce Kramer, Melis Lydston, Margaret C. Fang, Sachin J. Shah · 2024 · BMJ
75. Left ventricular geometry and outcomes in patients with atrial fibrillation: The AFFIRM Trial
    Stavros Z. Apostolakis, Renee M. Sullivan, Brian Olshansky, Gregory Y.H. Lip · 2013 · International Journal of Cardiology
76. Evidence-Based Cardiology in Hemodialysis Patients
    Michael Allon · 2013 · Journal of the American Society of Nephrology
77. Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
    Kuan H. Ng, Robert G. Hart, John W. Eikelboom · 2013 · Cardiology and Therapy
78. Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia
    Victoria Jacobs, Scott C. Woller, Scott M. Stevens, Heidi Thomas May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, JOHN D. DAY, J. Peter Weiss, Jeffrey S. Osborn et al. · 2015 · Journal of Cardiovascular Electrophysiology
79. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines
    Ron Pisters, Robert J. van Oostenbrugge, Iris L.H. Knottnerus, Cees B. de Vos, Anita Boreas, Jan Lodder, Martin H. Prins, Harry J.G.M. Crijns, Robert G. Tieleman · 2010 · EP Europace
80. The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9).
    Andrew Kerr, Michael J.A. Williams, Harvey Douglas White, Robert Neil Doughty, Chris Nunn, Gerard Patrick Devlin, Corina Grey, Mildred Lee, Charmaine Flynn, Maxine Rhodes et al. · 2016 · PubMed
81. Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
    Wenhua Li, Duo Huang, Chern‐En Chiang, Chu‐Pak Lau, Hung‐Fat Tse, Esther W. Chan, Ian Chi Kei Wong, Gregory Y.H. Lip, Pak‐Hei Chan, Chung‐Wah Siu · 2016 · Clinical Cardiology
82. Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study
    Anders Nissen Bonde, Paul Blanche, Laila Stærk, Thomas Alexander Gerds, Anna Gundlund, Gunnar Gislason, Christian Tobias Torp-Pedersen, Gregory Y.H. Lip, Mark Andrew Hlatky, Jonas Bjerring Olesen · 2019 · European Heart Journal
83. MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation
    Joan Martí‐Fábregas, Santiago Medrano-Martorell, Elisa Merino, Luís Prats‐Sánchez, Rebeca Marín, Raquel Delgado‐Mederos, Alejandro Martínez Domeño, Pol Camps‐Renom, Elena Jiménez‐Xarrié, Marialuisa Zedde et al. · 2019 · Neurology
84. Digital health in the era of personalized healthcare
    Jorge Cancela, Ilias Charlafti, Seya Colloud, Catherine Wu · 2020 · Elsevier eBooks
85. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation
    Shota Fukuda, Hiroyuki Watanabe, Kenei Shimada, Masaru Aikawa, Yasushi Kono, Satoshi Jissho, Haruyuki Taguchi, Jun Umemura, Minoru Yoshiyama, Takahiro Shiota et al. · 2011 · Journal of Cardiology
86. Individualized Medical Decision Making: Necessary, Achievable, but Not Yet Attainable
    L. Fraenkel, T. Fried · 2010 · Archives of Internal Medicine
87. Rivaroxaban, an oral direct factor Xa inhibitor
    Jonathan Paul Piccini, Manesh R. Patel, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf · 2008 · Expert Opinion on Investigational Drugs
88. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study
    Vivencio Barrios, Carlos Escobar, Luís Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García · 2015 · Revista Española de Cardiología (English Edition)
89. High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
    Roopinder Kaur Sandhu, Lisa R Dolovich, Bishoy Deif, Walid M. Barake, Gina Agarwal, Alex Grinvalds, Ting Lim, F. Russell Quinn, David J. Gladstone, David Conen et al. · 2016 · Open Heart
90. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy ― Warfarin vs. Direct Oral Anticoagulants ―
    Mihoko Kawabata, Masahiko Goya, Takeshi Sasaki, Shingo Maeda, Yasuhiro Shirai, Takuro Nishimura, Takakatsu Yoshitake, Shinya Shiohira, Mitsuaki Isobe, Kenzo Hirao · 2017 · Circulation Journal
91. Developing a Conversation Aid to Support Shared Decision Making: Reflections on Designing Anticoagulation Choice
    Claudia Liz Zeballos-Palacios, Ian G Hargraves, Peter A. Noseworthy, Megan E. Branda, Marleen Kunneman, Bruce Burnett, Michael R. Gionfriddo, Christopher John McLeod, Haeshik S. Gorr, Juan Pablo Brito et al. · 2019 · Mayo Clinic Proceedings
92. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage
    Rustam Al‐Shahi Salman, Martin S. Dennis, Peter AG Sandercock, Cathie L. M. Sudlow, Joanna Marguerite Wardlaw, William N. Whiteley, Gordon D. Murray, Jacqueline Stephen, Aryelly Rodríguez, Steff C. Lewis et al. · 2021 · JAMA Neurology
93. Left Atrial Appendage Occlusion Eliminates the Need for Warfarin
    David R. Holmes, Robert S. Schwartz · 2009 · Circulation
94. Hemorrhagic complications associated with dabigatran use
    Betty C. Chen, Aaron D. Viny, Fiona M. Garlich, Paul Andrew Basciano, Mary Ann Howland, Silas W. Smith, Robert S. Hoffman, Lewis S. Nelson · 2012 · Clinical Toxicology
95. Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy
    Naoual Bennaghmouch, A. J. W. M. de Veer, Kerstin Bode, Bakhtawar Khan Mahmoodi, Willem J.M. Dewilde, Gregory Y.H. Lip, Martina Brueckmann, Eva Kleine, Jurriën M. ten Berg · 2017 · Circulation
96. Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta‐analysis
    Sarah Takach Lapner, Natasha Cohen, Clive Kearon · 2014 · Journal of Thrombosis and Haemostasis
97. Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting
    Shuchita Agarwal, Dimitri Bennett, David J. Smith · 2010 · American Journal of Cardiovascular Drugs
98. Effect of Race/Ethnicity on the Efficacy of Warfarin
    Albert Yuh‐Jer Shen, Wansu Chen, Janis F. Yao, Somjot Singh Brar, Xunzhang Wang, Alan S. Go · 2008 · CNS Drugs
99. Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation
    Vanessa Roldán, Juan Antonio Vilchez, Sergio Manzano‐Fernández, Eva Jover, Josefa Gálvez, Carmen María Puche, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Francisco R. Marín · 2014 · Stroke
100. Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
     Ajay Srivastava, Michael Peter Hudson, Ihab Hamoud, João L. Cavalcante, Chetan Pai, Scott S. Kaatz · 2008 · Thrombosis Journal